These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15608532)

  • 1. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
    Gebo KA; Fleishman JA; Conviser R; Reilly ED; Korthuis PT; Moore RD; Hellinger J; Keiser P; Rubin HR; Crane L; Hellinger FJ; Mathews WC;
    J Acquir Immune Defic Syndr; 2005 Jan; 38(1):96-103. PubMed ID: 15608532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.
    Gebo KA; Fleishman JA; Reilly ED; Moore RD;
    Med Care; 2005 Sep; 43(9 Suppl):III23-30. PubMed ID: 16116306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005.
    Lillie-Blanton M; Stone VE; Snow Jones A; Levi J; Golub ET; Cohen MH; Hessol NA; Wilson TE
    Am J Public Health; 2010 Aug; 100(8):1493-9. PubMed ID: 19910347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.
    Cunningham WE; Markson LE; Andersen RM; Crystal SH; Fleishman JA; Golin C; Gifford A; Liu HH; Nakazono TT; Morton S; Bozzette SA; Shapiro MF; Wenger NS
    J Acquir Immune Defic Syndr; 2000 Oct; 25(2):115-23. PubMed ID: 11103041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dysthymia on receipt of HAART by minority HIV-infected women.
    Turner BJ; Fleishman JA
    J Gen Intern Med; 2006 Dec; 21(12):1235-41. PubMed ID: 17105522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of health care resources by HIV-infected white, African-American, and Hispanic men in the era before highly active antiretroviral therapy.
    Menke TJ; Giordano TP; Rabeneck L
    J Natl Med Assoc; 2003 Sep; 95(9):853-61. PubMed ID: 14527053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998.
    King WD; Minor P; Ramirez Kitchen C; Oré LE; Shoptaw S; Victorianne GD; Rust G
    J Epidemiol Community Health; 2008 Sep; 62(9):798-803. PubMed ID: 18701730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
    Fleishman JA; Gebo KA; Reilly ED; Conviser R; Christopher Mathews W; Todd Korthuis P; Hellinger J; Rutstein R; Keiser P; Rubin H; Moore RD;
    Med Care; 2005 Sep; 43(9 Suppl):III40-52. PubMed ID: 16116308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-related medical service use by rural/urban residents: a multistate perspective.
    Wilson LE; Korthuis T; Fleishman JA; Conviser R; Lawrence PB; Moore RD; Gebo KA
    AIDS Care; 2011 Aug; 23(8):971-9. PubMed ID: 21400307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in national antiretroviral prescribing patterns between black and white patients with HIV/AIDS, 1996-2006.
    Oramasionwu CU; Brown CM; Lawson KA; Ryan L; Skinner J; Frei CR
    South Med J; 2011 Dec; 104(12):794-800. PubMed ID: 22089356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.
    Chander G; Himelhoch S; Fleishman JA; Hellinger J; Gaist P; Moore RD; Gebo KA
    AIDS Care; 2009 May; 21(5):655-63. PubMed ID: 19444675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001.
    Rutstein RM; Gebo KA; Siberry GK; Flynn PM; Spector SA; Sharp VL; Fleishman JA
    Med Care; 2005 Sep; 43(9 Suppl):III31-9. PubMed ID: 16116307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for elimination of racial-ethnic disparities in HIV treatment initiation in the Medicaid population among 14 southern states.
    Zhang S; McGoy SL; Dawes D; Fransua M; Rust G; Satcher D
    PLoS One; 2014; 9(4):e96148. PubMed ID: 24769625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient patterns of care and longitudinal intensity of antiretroviral therapy for HIV-infected drug users.
    Laine C; Hauck WW; Turner BJ
    Med Care; 2002 Oct; 40(10):976-95. PubMed ID: 12395030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.
    Kahn JG; Zhang X; Cross LT; Palacio H; Birkhead GS; Morin SF
    Public Health Rep; 2002; 117(3):252-62; discussion 231-2. PubMed ID: 12432136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and ethnic disparities in postpartum care and contraception in California's Medicaid program.
    Thiel de Bocanegra H; Braughton M; Bradsberry M; Howell M; Logan J; Schwarz EB
    Am J Obstet Gynecol; 2017 Jul; 217(1):47.e1-47.e7. PubMed ID: 28263752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008.
    Mehta SH; Kirk GD; Astemborski J; Galai N; Celentano DD
    Clin Infect Dis; 2010 Jun; 50(12):1664-71. PubMed ID: 20450418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.
    Fu TC; Westergaard RP; Lau B; Celentano DD; Vlahov D; Mehta SH; Kirk GD
    AIDS; 2012 Nov; 26(18):2383-91. PubMed ID: 23079804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of medical insurance and other factors with receipt of antiretroviral therapy.
    Keruly JC; Conviser R; Moore RD
    Am J Public Health; 2002 May; 92(5):852-7. PubMed ID: 11988459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.
    Himelhoch S; Chander G; Fleishman JA; Hellinger J; Gaist P; Gebo KA
    Gen Hosp Psychiatry; 2007; 29(6):518-25. PubMed ID: 18022045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.